Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lexapro in Major Depressive Disorder (PET/MRI study)
NCT02623205Phase 4Completed
- Sponsor
- Stony Brook University
- Start
- May 2015
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Stony Brook University. Started May 2015; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02623205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02623205.